0000899243-23-007196.txt : 20230306
0000899243-23-007196.hdr.sgml : 20230306
20230306172803
ACCESSION NUMBER: 0000899243-23-007196
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230302
FILED AS OF DATE: 20230306
DATE AS OF CHANGE: 20230306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gebski Christine
CENTRAL INDEX KEY: 0001849585
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 23710069
MAIL ADDRESS:
STREET 1: C/O REPLIGEN CORPORATION
STREET 2: 41 SYON ST. BLDG. 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-02
0
0000730272
REPLIGEN CORP
RGEN
0001849585
Gebski Christine
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
0
1
0
0
See Remarks
Common Stock
2023-03-02
4
A
0
3467
0.00
A
32660
D
Common Stock
2023-03-03
4
A
0
375
0.00
A
33035
D
Common Stock
2023-03-03
4
F
0
126
188.00
D
32909
D
Stock Option (Right to Buy)
180.48
2023-03-02
4
A
0
3590
0.00
A
2033-03-02
Common Stock
3590
3590
D
Ms. Gebski was awarded 3,467 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
Represents shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on January 1, 2022. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award.
Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the settlement of the PSUs.
One third of the stock options will vest and become exercisable annually on March 2, 2024, March 2, 2025, and March 2, 2026.
SVP, Filtration & Chromatography
/s/ Kimberly Brown (Attorney in Fact)
2023-03-06